Adma Biologics reported $23.37M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Adma Biologics USD 23.37M 1.22M Jun/2025
Alnylam Pharmaceuticals USD 323.31M 83.36M Jun/2025
Dynavax Technologies USD 41.54M 64.79M Jun/2025
Takeda JPY 255.89B 39.98B Jun/2025